HCS Pharma is a biotech start-up focused on in vitro preclinical R&D. They specialize in phenotypic screening of physiologically relevant 3D cell models that also consider the extracellular matrix (ECM). See how the team save time and money with automated High-Content Screening (HCS) and imaging approaches, in collaboration with Molecular Devices…
In this unique new five-part weekly webinar series, Molecular Devices scientists will introduce you to various aspects of microplate reader technology in an educational and entertaining way. Starting with some basic concepts, they will explain a number of ‘urban myths’ or misconceptions each week - as well as introducing a variety of theories and technologies – ultimately enabling you to fully understand the choices you make when writing protocols, choosing a new microplate reader or optimizing an existing assay.
More than 305,000 high-resolution, multi-channel COVID-19 cellular images captured in less than four weeks with Molecular Devices ImageXpress® Micro Confocal High-Content Imaging System are now available to the scientific community. With the COVID-19 pandemic impacting millions around the globe, researchers are racing to develop a vaccine or drug treatment. In an effort to better understand the cellular responses to COVID-19, the digital biology company Recursion has publicly released the world’s largest imaging dataset....
Cellular imaging acquisition and analysis system at an affordable price point. Molecular Devices, LLC, a leader in protein and cell biology technologies,has announced the launch of its ImageXpress® Pico Automated Cell Imaging System. Building on over 20 years of experience in the high content imaging space, this compact, affordable imaging system brings the power of both imaging and analysis to the individual lab bench....
Announcing the Single-Cell Printer for documented isolation of cells in clonal cell line development
Molecular Devices, LLC, a leader in protein and cell biology technologies, have announced a partnership with Cytena GmbH to launch the CloneSelect™ Single-Cell Printer™ in North America. This novel system utilizes sophisticated microfluidics-based technology and real-time image analysis to isolate single cells....
In a move to serve customers with ready-to-use solutions for organ-on-a-chip model development and analysis, MIMETAS and Molecular Devices will combine marketing efforts on the OrganoPlate® organ-on-a-chip platform and ImageXpress® Micro Confocal high-content imaging systems.
This agreement was announced at the SLAS2017 conference in Washington. “OrganoPlates® are designed for ease-of-handling at any throughput, and provide unsurpassed physiological relevance,” said Jos Joore, Managing Director of MIMETAS, “As such, they are perfectly suited for the high-content imaging systems from Molecular Devices....
Sensitive, flexible, field-upgradeable system supports a wide range of applications
Molecular Devices®, the market leader in microplate reader technology for over 25 years, has announced today the next-generation SpectraMax® MiniMax™ 300 Imaging Cytometer. This MiniMax 300 imaging cytometer enables both cellular visualization and first-of- its-kind stain free cell-based analysis on the field-upgradable SpectraMax® i3 Multi-Mode Microplate Reader. Brightfield and fluorescence based green and red channel cellular image acquisition and analysis is made simple using the SoftMax Pro® software workflow....
Molecular Devices, market leader in the electrophysiology and biophysical research markets for over 30 years, announced today the launch of its next generation Axon™ Digidata® 1550 Low-Noise Data Acquisition System.
Considered the industry standard in neuroscience research labs, the new Digidata Platform enables the parallel patching of up to eight cells simultaneously to provide better insight of neuronal network function and capture more data points per experiment. This new system extends the precision and quality of the existing Axon Digitizer platform to include a higher sampling rate to monitor rapid responders, combined with enhanced performance in low-noise, high resolution 16-bit data acquisition....
Molecular Devices will be showcasing their SpectraMax® i3 multi-mode microplate reader and AquaMax® Washer during LaboTec Suisse
The SpectraMax® i3 Multi-Mode Detection Platform is available as a stand-alone reader with three broad detection modes: luminescence, absorbance, and fluorescence. Users are then given the option to upgrade to additional applications and detection modes which expands the system's detection capability making it highly versatile, and able to offer application options far exceeding those of standard readers...
Molecular Devices will be showcasing their ImageXpress® Micro XL, FLIPR® Calcium 6 assay kits and SpectraMax® i3 during Drug Discovery Innovations and Interact 2013
The SpectraMax® i3 Multi-Mode Detection Platform is available as a stand-alone reader with three broad detection modes: luminescence, absorbance, and fluorescence. Users are then given the option to upgrade to additional applications and detection modes which expands the system's detection capability making it highly versatile, and able to offer application options far exceeding those of standard readers. Additional detection modules include cellular imaging with the SpectraMax® MiniMax™ Imaging Cytometer, and cartridges for Time-Resolved Fluorescence, Fluorescence Polarization, and AlphaScreen® assays...
Molecular Devices have announced the launch of their SoftMax® Pro 6 GxP Software, for data acquisition and analysis for microplate readers in regulated environments. The software additionally supports the SpectraMax® Paradigm® Multi-Mode Detection Platform and FilterMax™ F3/F5 Microplate Readers
SoftMax Pro 6 GxP Software facilitates easy upgrades for existing users from previous software versions with its unique "plug-in" feature that allows existing databases to be integrated without the need to re-establish and revalidate the whole system, thereby decreasing time and resources needed for this stage which can be costly and inefficient. A custom-designed validation package supports the software such as printable IQ-OQ worksheets, extensive tests for data analysis features, easy-to-follow instructions and ready-to-use sample data to streamline the software validation process making it easy and fast to validate this powerful data analysis tool...
Molecular Devices®, market leader in microplate reader technology for over 25 years, has announced the launch of its SpectraMax® i3 Multi-Mode Detection Platform
The system is available as a stand-alone reader with the option for users to upgrade to additional applications and detection modes such as cellular imaging with the SpectraMax® MiniMax™ Imaging Cytometer, and cartridges for Time-Resolved Fluorescence, Fluorescence Polarization, and AlphaScreen® assays. The highly sensitive instrument accommodates the budget and throughput needs of both small and large laboratories alike...
HCS Pharma is a biotech start-up focused on in vitro preclinical R&D. They specialize in phenotypic screening of physiologically relevant 3D cell models that also consider the extracellular matrix (ECM). See how the team save time and money with automated High-Content Screening (HCS) and imaging approaches, in collaboration with Molecular Devices…
In this unique new five-part weekly webinar series, Molecular Devices scientists will introduce you to various aspects of microplate reader technology in an educational and entertaining way. Starting with some basic concepts, they will explain a number of ‘urban myths’ or misconceptions each week - as well as introducing a variety of theories and technologies – ultimately enabling you to fully understand the choices you make when writing protocols, choosing a new microplate reader or optimizing an existing assay.
Cellular imaging acquisition and analysis system at an affordable price point. Molecular Devices, LLC, a leader in protein and cell biology technologies,has announced the launch of its ImageXpress® Pico Automated Cell Imaging System. Building on over 20 years of experience in the high content imaging space, this compact, affordable imaging system brings the power of both imaging and analysis to the individual lab bench....
Molecular Devices, LLC, a leader in protein and cell biology technologies, have announced a partnership with Cytena GmbH to launch the CloneSelect™ Single-Cell Printer™ in North America. This novel system utilizes sophisticated microfluidics-based technology and real-time image analysis to isolate single cells....
Molecular Devices®, the market leader in microplate reader technology for over 25 years, has announced today the next-generation SpectraMax® MiniMax™ 300 Imaging Cytometer. This MiniMax 300 imaging cytometer enables both cellular visualization and first-of- its-kind stain free cell-based analysis on the field-upgradable SpectraMax® i3 Multi-Mode Microplate Reader. Brightfield and fluorescence based green and red channel cellular image acquisition and analysis is made simple using the SoftMax Pro® software workflow....
Considered the industry standard in neuroscience research labs, the new Digidata Platform enables the parallel patching of up to eight cells simultaneously to provide better insight of neuronal network function and capture more data points per experiment. This new system extends the precision and quality of the existing Axon Digitizer platform to include a higher sampling rate to monitor rapid responders, combined with enhanced performance in low-noise, high resolution 16-bit data acquisition....
The SpectraMax® i3 Multi-Mode Detection Platform is available as a stand-alone reader with three broad detection modes: luminescence, absorbance, and fluorescence. Users are then given the option to upgrade to additional applications and detection modes which expands the system's detection capability making it highly versatile, and able to offer application options far exceeding those of standard readers...
The SpectraMax® i3 Multi-Mode Detection Platform is available as a stand-alone reader with three broad detection modes: luminescence, absorbance, and fluorescence. Users are then given the option to upgrade to additional applications and detection modes which expands the system's detection capability making it highly versatile, and able to offer application options far exceeding those of standard readers. Additional detection modules include cellular imaging with the SpectraMax® MiniMax™ Imaging Cytometer, and cartridges for Time-Resolved Fluorescence, Fluorescence Polarization, and AlphaScreen® assays...
SoftMax Pro 6 GxP Software facilitates easy upgrades for existing users from previous software versions with its unique "plug-in" feature that allows existing databases to be integrated without the need to re-establish and revalidate the whole system, thereby decreasing time and resources needed for this stage which can be costly and inefficient. A custom-designed validation package supports the software such as printable IQ-OQ worksheets, extensive tests for data analysis features, easy-to-follow instructions and ready-to-use sample data to streamline the software validation process making it easy and fast to validate this powerful data analysis tool...
The system is available as a stand-alone reader with the option for users to upgrade to additional applications and detection modes such as cellular imaging with the SpectraMax® MiniMax™ Imaging Cytometer, and cartridges for Time-Resolved Fluorescence, Fluorescence Polarization, and AlphaScreen® assays. The highly sensitive instrument accommodates the budget and throughput needs of both small and large laboratories alike...